July/August/September 2022

Insights

Podcasts

The Value and Opportunity in Individualized Cancer Care: Part 1

09/08/2022

Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discusses the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.

Gordon Kuntz; Bryan Loy, MD,...

09/08/2022

Journal of Clinical Pathways

Interview

Integrating Clinical Pathways Into OptumCare Practices

09/08/2022

Ann Nguyen , PharmD;

Winston Wong , PharmD;

Ann Nguyen from OptumCare discusses her efforts to implement clinical pathways into the OptumCare family of medical practices while addressing the financial risks of this venture, and the main goals and focuses of this clinical pathways...

Ann Nguyen from OptumCare...

09/08/2022

Journal of Clinical Pathways

Column

Editor's Page

A Call to Action

09/08/2022

Winston Wong , PharmD;

Editor-in-Chief, Winston Wong, PharmD, outlines the latest issue of Journal of Clinical Pathways.

Editor-in-Chief, Winston Wong,...

09/08/2022

Journal of Clinical Pathways

Trending From ACCC

ACCC Webinar Offers Strategies to Help Health Care Organizations Combat the Great Resignation

09/08/2022

Stephanie Helbling ;

The ACCC partnered with Hallmark Health Care Solutions to host a live broadcast where expert panelists discussed barriers and effective practices to ensure the recruitment and retainment of a quality workforce.

The ACCC partnered with Hallmark...

09/08/2022

Journal of Clinical Pathways

Feature

Research Reports

08/15/2022

Kathryn Christensen , MD, MS;

Timothy Dollear , MD, MS;

Eric Gratias , MD, FAAP;

Christopher Linkimer , CPA;

Margaret Rausa , PharmD;

Nick Andrews , PharmD;

Stephen Hamilton , MD;

Dr Hamilton and colleagues outline how eviCore Healthcare offered the option for payer clients to implement a biosimilar preferencing policy, analyzing how this policy affected the rate of biosimilar use and costs.

Dr Hamilton and colleagues...

08/15/2022

Journal of Clinical Pathways

Research Reports

Phase II: A Value-Based Collaborative Care Model by Payers, Providers, and Pharma

08/11/2022

Mary Aikins , RN, CCM;

Lili Brillstein , MPH;

Michael Udwin , MD, FACOG;

Eric McCulley , RN;

A group of stakeholders determined several key challenges to delivering care to patients with psoriatic arthritis, and highlighted several points that should be considered when building a value-based care model for this patient group.

A group of stakeholders...

08/11/2022

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

July/August/September 2022

Insights

Column

Feature

Current Issue

Special Reports

Subscribe

September 2022 Volume 8 Issue 6

Specialties

Events

Year Round Education

HMP Global Products